Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019
Neisseria meningitidis serogroup B (MenB) is the most common cause of meningococcal disease in adolescents and young adults.In Australia, MenB vaccination has been available through private prescription since 2014 and has been recommended for at-risk groups including adolescents, young adults who smoke and people medically at risk.For each of these